In diabetic nephropathy conditions, dihydromyricetin promoted autophagy through the regulation of miR-155-5p and its target gene PTEN and PI3K/AKT/mTOR pathway under both in vitro and in vivo conditions [234]. This evidence concerns the gene MTOR and diabetic kidney disease.